Literature DB >> 19185062

Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia.

Yan Xu1, Yang Xue, Ying Wang, Dechun Feng, Shuting Lin, Lingyun Xu.   

Abstract

Microglial activation has been implicated in many neurological disorders for its inflammatory and/or neurotrophic effects. In this study, we investigated the effects upon activated microglia of Oridonin (Ori), an effective component isolated from Rabdosia rubescens. We pretreated rat primary microglia with or without Ori, then stimulated with lipopolysaccharide (LPS). We found that Ori pretreatment inhibited the release of proinflammatory mediators including nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta) and interleukin-6 (IL-6). Such suppressive effects were accompanied by inhibition of DNA binding activity of the critical transcription factor nuclear factor-kappa B (NF-kappaB). In addition, Ori upregulated the production of the neurotrophic factor, nerve growth factor (NGF). Our findings suggest that Ori may have anti-inflammatory and neuroregulatory effects through modulation of multiple functions of microglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185062     DOI: 10.1016/j.intimp.2009.01.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  26 in total

1.  Oridonin induces G2/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells.

Authors:  Jianlei Lu; Xiang Chen; Shuang Qu; Bing Yao; Yuexin Xu; Jiahui Wu; Yucui Jin; Changyan Ma
Journal:  Oncol Lett       Date:  2017-02-20       Impact factor: 2.967

Review 2.  Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.

Authors:  Ara Aboolian; Sofia Urner; Michael Roden; Jay Chandra Jha; Karin Jandeleit-Dahm
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  J Surg Res       Date:  2015-08-05       Impact factor: 2.192

Review 4.  Oridonin: targeting programmed cell death pathways as an anti-tumour agent.

Authors:  Z Liu; L Ouyang; H Peng; W-Z Zhang
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

5.  The changing phenotype of microglia from homeostasis to disease.

Authors:  Xiao-Guang Luo; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-04-24       Impact factor: 8.014

Review 6.  Molecular Insight in the Multifunctional Effects of Oridonin.

Authors:  Brice Ayissi Owona; Herman J Schluesener
Journal:  Drugs R D       Date:  2015-09

7.  Oridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathway.

Authors:  Sulei Wang; Hui Yang; Linjie Yu; Jiali Jin; Lai Qian; Hui Zhao; Yun Xu; Xiaolei Zhu
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 8.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.

Authors:  Xi Liu; Jimin Xu; Jia Zhou; Qiang Shen
Journal:  Genes Dis       Date:  2020-07-05

9.  Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Rolf Daniels; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2013-09-05       Impact factor: 5.310

10.  Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Chaoyun Li; Caroline Zug; Hermann J Schluesener
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.